Literature DB >> 10827970

Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine diseases.

H Monoi1, S Futaki, S Kugimiya, H Minakata, K Yoshihara.   

Abstract

We report that long-chain poly-L-glutamine forms cation-selective channels when incorporated into artificial planar lipid bilayer membranes. The channel was permeable to alkali cations and H(+) ions and virtually impermeable to anions; the selectivity sequence based on the single-channel conductance was H(+) >> Cs(+) > K(+) > Na(+). The cation channel was characterized by long-lived open states (often lasting for several minutes to tens of minutes) interrupted by brief closings. The appearance of the channel depended critically on the length of polyglutamine chains; ion channels were observed with 40-residue stretches, whereas no significant conductance changes were detected with 29-residue tracts. The channel-forming threshold length of poly-L-glutamine was thus between 29 and 40 residues. A molecular mechanics calculation suggests a mu-helix (. Biophys. J. 69:1130-1141) as a candidate molecular structure of the channel. The channel-forming nature of long-chain poly-L-glutamine may provide a clue to the elucidation of the pathogenetic mechanism of the polyglutamine diseases, a group of inherited neurodegenerative disorders including Huntington's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827970      PMCID: PMC1300875          DOI: 10.1016/s0006-3495(00)76830-5

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  43 in total

1.  Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues.

Authors:  T V Strong; D A Tagle; J M Valdes; L W Elmer; K Boehm; M Swaroop; K W Kaatz; F S Collins; R L Albin
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

2.  Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism.

Authors:  H Green
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

3.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.

Authors:  R G Snell; J C MacMillan; J P Cheadle; I Fenton; L P Lazarou; P Davies; M E MacDonald; J F Gusella; P S Harper; D J Shaw
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

4.  Trinucleotide repeat length instability and age of onset in Huntington's disease.

Authors:  M Duyao; C Ambrose; R Myers; A Novelletto; F Persichetti; M Frontali; S Folstein; C Ross; M Franz; M Abbott
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

5.  Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.

Authors:  N Arispe; H B Pollard; E Rojas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

6.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15.

Authors:  O C Stine; N Pleasant; M L Franz; M H Abbott; S E Folstein; C A Ross
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

7.  Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA).

Authors:  R Koide; T Ikeuchi; O Onodera; H Tanaka; S Igarashi; K Endo; H Takahashi; R Kondo; A Ishikawa; T Hayashi
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

8.  A study of the Huntington's disease associated trinucleotide repeat in the Scottish population.

Authors:  L H Barron; J P Warner; M Porteous; S Holloway; S Simpson; R Davidson; D J Brock
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

9.  Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p.

Authors:  S Nagafuchi; H Yanagisawa; K Sato; T Shirayama; E Ohsaki; M Bundo; T Takeda; K Tadokoro; I Kondo; N Murayama
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

10.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues.

Authors:  S H Li; G Schilling; W S Young; X J Li; R L Margolis; O C Stine; M V Wagster; M H Abbott; M L Franz; N G Ranen
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

View more
  15 in total

1.  Therapeutic effects of cystamine in a murine model of Huntington's disease.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Thomas M Jeitner; Samantha A Matson; Misha Bogdanov; Neil W Kowall; Wayne R Matson; Arthur J L Cooper; Rajiv R Ratan; M Flint Beal; Steven M Hersch; Robert J Ferrante
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 2.  From Alzheimer to Huntington: why is a structural understanding so difficult?

Authors:  Piero Andrea Temussi; Laura Masino; Annalisa Pastore
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

3.  Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease.

Authors:  Rajeev K Chaudhary; Kinjal A Patel; Milan K Patel; Radha H Joshi; Ipsita Roy
Journal:  Mol Ther       Date:  2015-08-27       Impact factor: 11.454

4.  Evidence that Perutz's double-beta-stranded subunit structure for beta-amyloids also applies to their channel-forming structures in membranes.

Authors:  S Jonathan Singer; Nazneen N Dewji
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 5.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

Review 6.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

7.  Tau oligomers impair artificial membrane integrity and cellular viability.

Authors:  Katharina Flach; Isabel Hilbrich; Andrea Schiffmann; Ulrich Gärtner; Martin Krüger; Marion Leonhardt; Hanka Waschipky; Lukas Wick; Thomas Arendt; Max Holzer
Journal:  J Biol Chem       Date:  2012-11-05       Impact factor: 5.157

8.  Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals.

Authors:  Alexander V Panov; Serena Lund; J Timothy Greenamyre
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

9.  Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein.

Authors:  Georg Künze; Patrick Barré; Holger A Scheidt; Lars Thomas; David Eliezer; Daniel Huster
Journal:  Biochim Biophys Acta       Date:  2012-04-06

10.  Probing the Huntingtin 1-17 membrane anchor on a phospholipid bilayer by using all-atom simulations.

Authors:  Sébastien Côté; Vincent Binette; Evgeniy S Salnikov; Burkhard Bechinger; Normand Mousseau
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.